In both syngeneic transplant and endogenous mouse tumor models, genetic deletion of FAP or pharmacologic inhibition of its enzymatic activity led to excessive accumulation and disorganization of collagen and decrease in myofibroblast content and blood vessel density in tumors, thus inhibiting tumor growth (30). The gene discussed is FAP; the disease is neoplasm.